Services

Offering complex, technologically advanced platforms targeting serious human disease

Contract Development

  1. Formulation Development
  2. Analytical development
  3. Stability Studies
  4. Regulatory affairs
  5. Clinical affairs
  6. Intellectual property

Dosage Forms

  1. Solids
    1. Tablets ( micro to multi layer)
    2. Capsules (multi particulate to combo API)
    3. Film coated oral dosage forms
  2. Semi Solids
    1. Gels
    2. Creams
    3. Ointments
    4. Lotions
  3. Liquids
    1. Syrups
    2. Solutions
    3. Emulsions
    4. Suspensions
  4. Speciality
    1. Suppositories
    2. Opthalmics
    3. Injectables
    4. Inhalation

Technology Solutions

  1. Blending
  2. Dry Granulation/Roller Compaction
  3. Wet Granulation
  4. Fluid Bed Drying
  5. Spray Drying
  6. Twin screw Extrusion
  7. Spheronization
  8. Encapsulation
  9. Tableting (Micro and Multi-Layer)
  10. Pan Coating/Drying
  11. Mixing
  12. Homogenization
  13. Filling
  14. Lyophilization

Technology Platforms

  1. Solid oral
    1. Osmotic drug delivery systems (OROS)
    2. Matrix Drug delivery system
    3. Multiple Unit particulate system (MUPS)
    4. Hot Melt Extrusion
    5. Spray Drying
  2. Semi Solids
    1. Gels / Emulgels
    2. Foam/ Sprays (topical / Nasal)
    3. Micro/ Nanoemulsion
  3. Liquids
    1. CR Liquids
    2. Sol-Gel Transition paediatric liquids
    3. SMEDDS / SNEDDS
    4. Micro- Nanosuspensions
    5. Oral / sublingual spray
  4. Injectable
    1. Particle engineering
    2. Lyophillised
    3. Gelling systems in-situ
    4. Crystal modification
  5. Nasal and Inhalation
    1. Particle Engineering for DPI
    2. Co-delivery of drugs by Co-crystal formation
    3. Nebulizing solutions and suspensions
    4. Nasal drug delivery
    5. MDIs

R&D Collaborative Solutions

  1. Bioavalability enhancement
  2. Co delivery of drugs
  3. Extended duration of drug release
  4. Twin screw continuous granulation

Patient centric drug delivery

  1. Unimodal/ bimodal release profiles
  2. Delayed/ controlled release profiles
  3. PK/ PD modelling for abridged path forward
  4. Development of high barrier intellectual property with use of technology barriers ( Osmotics, MUPS, CR / ER / Solid dispersion/ Co-crystals)